The full content of Annals is available to subscribers

Subscribe/Learn More  >
Ideas and Opinions |

Breaking the Camel's Back: Multicenter Clinical Trials and Local Institutional Review Boards

William J. Burman, MD; Randall R. Reves, MD; David L. Cohn, MD; and Robert T. Schooley, MD
[+] Article, Author, and Disclosure Information

From Denver Health and Hospital Authority and University of Colorado Health Sciences Center, Denver, Colorado.

Presented in part to the National Bioethics Advisory Commission, Washington, D.C., 11 July 2000.

Acknowledgments: The authors thank Andrew Vernon, MD, MPH; Jack Rouff, MSW; and C. Robert Horsburgh, MD, for manuscript review and discussions.

Requests for Single Reprints: William J. Burman, MD, Denver Public Health, 605 Bannock Street, Denver, CO 80204; e-mail, bburman@dhha.org.

Current Author Addresses: Drs. Burman, Reves, and Cohn: Denver Public Health, 605 Bannock Street, Denver, CO 80204.

Dr. Schooley: Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262.

Ann Intern Med. 2001;134(2):152-157. doi:10.7326/0003-4819-134-2-200101160-00016
Text Size: A A A

Clinical research has undergone remarkable and beneficial expansion in the past 25 years, but with this growth has come an unprecedented increase in workload for the human subjects protection system. Recently, a major change in federal oversight of local institutional review boards (IRBs) became evident. Although it was not announced publicly, in 1998 and 1999 federal regulatory actions against local IRBs increased threefold. Particularly notable was the marked increase in regulatory actions taken against the IRBs of academic medical centers (1 in 1997 compared with 14 in 1999). Ironically, this apparent federal crackdown began at the same time that two federal review panels called for major changes in the regulations governing local IRBs. A key factor in the current crisis in the function of local IRBs is the ascendance of multicenter clinical trials as the dominant form of clinical research. Local IRBs were not designed to handle the initial evaluation and ongoing review required by the rapidly increasing number of multicenter clinical trials. Furthermore, local IRB review of the thousands of safety reports from multicenter clinical trials monopolizes resources without promoting patient safety. Instead of rigid enforcement of outmoded regulations that do not contribute to patient safety, the responsibilities of the local IRB in the oversight of multicenter clinical trials must be systematically evaluated.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.